Selected Publications

Ashraf Alzahrani, Kaushik Gokul, Aswathi Paleri, Edward M Powers, Steven Bailin, Eric H Yang, Michael Fradley, Peter Farjo, Paari Dominic : New-onset atrial fibrillation as a predictor of cancer: Insights from a real-world dataset. Heart Rhythm 2025.

Malak El-Rayes, Mohamed Adam, Jiming Fang, Xuesong Wang, Irene Jeong, Peter C Austin, Andrew C T Ha, Michael G Fradley, Thomas A Boyle, Eitan Amir, Paaladinesh Thavendiranathan, Husam Abdel-Qadir: The Association of Malignancy With Stroke and Bleeding in Atrial Fibrillation: A Population-Based Cohort Study. JACC CardioOncology 7(2): 157-167, 2025.

Matthew A Barrett, Biniyam G Demissei, Ray Hu, Amanda M Smith, Gary Freedman, John Plastaras, Steven Feigenberg, Eva Berlin, Hari K Narayan, Benedicte Lefebvre, Marielle Scherrer Crosbie, Michael Fradley, Joseph Carver, Jinbo Chen, Bonnie Ky : 3D Echocardiographic Phenotyping of Left Ventricular Mechanics and Function With Contemporary Radiation Therapy. Advances in Radiation Oncology 10(7), 2025.

Stephen C Cook, Geoffrey D Barnes, Kathryn Berlacher, Quinn Capers 4th, Michael G Fradley, Leigh C Reardon, Anne Rzeszut, Melanie Sulistio, Melvin Echols : Experiences of Lesbian, Gay, Bisexual, Transgender, and Queer Cardiology Physicians and Fellows in Training. JACC Advances 4(2), 2025.

Lakshya Seth, Nickolas Stabellini, Shawn Doss, Vraj Patel, Viraj Shah, Gregory Lip, Susan Dent, Michael G Fradley, Lars Køber, Avirup Guha: Atrial fibrillation and ischemic stroke in cancer: the latest scientific evidence, current management, and future directions. Journal of Thrombosis and Thrombolysis 2025.

Daniel Lenihan, Michelle Bloom, Robert Copeland-Halperin, Matthew R Fleming, Michael Fradley, Rupal O'Quinn, Seema A Bhat : Considerations for the practical management of cardiovascular risk with Bruton's tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia. Oncologist 30(9), 2025.

Daniel S Lefler, Elise F Nassif Haddad, Anju Nohria, Mark Agulnik, Jacquelyn Crane, Michael G Fradley: Sarcoma: Cardiovascular and Oncologic Considerations: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncology 2025.

Udhayvir S Grewal, Stefano H Byer, Sidharth Mahajan, Aakash R Sheth, Kavitha Beedupalli, Michael G Fradley, Eric H Yang, Andrea M Russo, Aarti Asnani, Paari Dominic : Atrial Fibrillation and Cancer: Bidirectional Relationship and Potential for Personalized Care. JACC Clinical Electrophysiology 2025.

Joerg Herrmann, Ana Barac, Joseph Carver, Richard K Cheng, Andres Daniele, Susan Dent, Elena Deych, Dae Hyun Lee, Daniel Lenihan, Darryl P Leong, Jennifer Liu, Teresa Lopez-Fernandez, Alexander R Lyon, Michael Fradley, Ariane V S Macedo, Meghan J Mooradian, Anju Nohria, Charles Porter, Tienush Rassaf, Giselle Suero-Abreu, Aaron L Sverdlov, Paaladinesh Thavendiranathan, Tomas G Neilan, Joshua D Mitchell: Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position Statement. JAMA Oncology 2025.

Lakshya Seth, Nickolas Stabellini, Aditya Bhave, Gaurav Gopu, Sandeep Yerraguntla, Ahmed Shetewi, John Lester, Vraj Patel, Stephanie Jiang, Madison James, Stanley Joseph, Sai Kollapaneni, Viraj Shah, Susan Dent, Michael G Fradley, Lars Køber, Anne Blaes, Avirup Guha: The B-S2CALED Score's Utility in Predicting Stroke Risk in Breast Cancer Patients with Atrial Fibrillation. Cancers (Basel) 2025.